January 13, 2022
University of Cincinnati researchers have received a U.S. Department of Defense grant to further study how stress hormone receptors affect brain cell degeneration in Parkinson's disease.
January 18, 2022
Mixmag Magazine featured University of Cincinnati research studying how a mobile app where patients can stream and create their own music can help treat brain fog.
January 20, 2022
University of Cincinnati researcher physicians are hosting the BEAT-MS trial which will study the effectiveness of stem cell transplant compared to the currently best available treatments for multiple sclerosis.
January 25, 2022
The University of Cincinnati's Dr. Timothy Phoenix has received three separate grants from philanthropic organizations and the National Institutes of Health to learn more about the genetic workings of pediatric diffuse midline gliomas, a deadly brain tumor.
January 25, 2022
The University of Cincinnati's Dr. Wenhai Shao, PhD, was featured in a Reuters Health article reviewing a study of COVID-19 vaccines' effect on patients with rheumatic and musculoskeletal diseases.
January 26, 2022
Innovate Healthcare featured comments from University of Cincinnati radiologists Achala Vagal and Luca Saba in an article about the future of how artificial intelligence can help move stroke care forward.
January 27, 2022
WVXU highlighted the work of University of Cincinnati professor Dr. Kate Chard at the Cincinnati VA, which involves cutting edge research and evidence-based treatments for veterans with post-traumatic stress disorder.
January 31, 2022
WVXU featured the University of Cincinnati's Dr. Ishita Basu, who is leading research to see how brain stimulation can help treat mental health disorders.
January 31, 2022
55KRC's Simply Medicine program highlighted the University of Cincinnati's Dr. Joseph Broderick and the FASTEST stroke clinical trial.
February 2, 2022
The University of Cincinnati's Chad Zender is leading a clinical trial studying if using a combination of Cesium-131 radioactive seeds and immunotherapy can be more effective and provide better quality of life than current treatments for patients with recurrent head and neck cancer.